These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26859850)

  • 21. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.
    Van Laere K; Ahmad RU; Hudyana H; Dubois K; Schmidt ME; Celen S; Bormans G; Koole M
    J Nucl Med; 2013 Aug; 54(8):1285-93. PubMed ID: 23843566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping of serotonin transporters by positron emission tomography with [11C]DASB in conscious common marmosets: comparison with rhesus monkeys.
    Yokoyama C; Yamanaka H; Onoe K; Kawasaki A; Nagata H; Shirakami K; Doi H; Onoe H
    Synapse; 2010 Aug; 64(8):594-601. PubMed ID: 20340166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new positron emission tomography imaging agent for the serotonin transporter: synthesis, pharmacological characterization, and kinetic analysis of [11C]2-[2-(dimethylaminomethyl)phenylthio]-5-fluoromethylphenylamine ([11C]AFM).
    Huang Y; Hwang DR; Bae SA; Sudo Y; Guo N; Zhu Z; Narendran R; Laruelle M
    Nucl Med Biol; 2004 Jul; 31(5):543-56. PubMed ID: 15219271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial Evaluation of an Adenosine A
    Sakata M; Ishibashi K; Imai M; Wagatsuma K; Ishii K; Zhou X; de Vries EFJ; Elsinga PH; Ishiwata K; Toyohara J
    J Nucl Med; 2017 Sep; 58(9):1464-1470. PubMed ID: 28280214
    [No Abstract]   [Full Text] [Related]  

  • 25. Positron emission tomography quantification of [(11)C]-DASB binding to the human serotonin transporter: modeling strategies.
    Ginovart N; Wilson AA; Meyer JH; Hussey D; Houle S
    J Cereb Blood Flow Metab; 2001 Nov; 21(11):1342-53. PubMed ID: 11702049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin transporter availability in patients with schizophrenia: a positron emission tomography imaging study with [11C]DASB.
    Frankle WG; Narendran R; Huang Y; Hwang DR; Lombardo I; Cangiano C; Gil R; Laruelle M; Abi-Dargham A
    Biol Psychiatry; 2005 Jun; 57(12):1510-6. PubMed ID: 15953487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association Between Lack of Insight and Prefrontal Serotonin Transporter Availability in Antipsychotic-Free Patients with Schizophrenia: A High-Resolution PET Study with [
    Kim JH; Son YD; Kim HK; Kim JH
    Neuropsychiatr Dis Treat; 2021; 17():3195-3203. PubMed ID: 34707358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin Synthesis and Reuptake in Social Anxiety Disorder: A Positron Emission Tomography Study.
    Frick A; Åhs F; Engman J; Jonasson M; Alaie I; Björkstrand J; Frans Ö; Faria V; Linnman C; Appel L; Wahlstedt K; Lubberink M; Fredrikson M; Furmark T
    JAMA Psychiatry; 2015 Aug; 72(8):794-802. PubMed ID: 26083190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A PET imaging agent with fast kinetics: synthesis and in vivo evaluation of the serotonin transporter ligand [11C]2-[2-dimethylaminomethylphenylthio)]-5-fluorophenylamine ([11C]AFA).
    Huang Y; Narendran R; Bae SA; Erritzoe D; Guo N; Zhu Z; Hwang DR; Laruelle M
    Nucl Med Biol; 2004 Aug; 31(6):727-38. PubMed ID: 15246363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin Transporter Binding in the Human Brain After Pharmacological Challenge Measured Using PET and PET/MR.
    Silberbauer LR; Gryglewski G; Berroterán-Infante N; Rischka L; Vanicek T; Pichler V; Hienert M; Kautzky A; Philippe C; Godbersen GM; Vraka C; James GM; Wadsak W; Mitterhauser M; Hacker M; Kasper S; Hahn A; Lanzenberger R
    Front Mol Neurosci; 2019; 12():172. PubMed ID: 31354428
    [No Abstract]   [Full Text] [Related]  

  • 31. The serotonin transporter in rhesus monkey brain: comparison of DASB and citalopram binding sites.
    Zeng Z; Chen TB; Miller PJ; Dean D; Tang YS; Sur C; Williams DL
    Nucl Med Biol; 2006 May; 33(4):555-63. PubMed ID: 16720249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered interregional correlations between serotonin transporter availability and cerebral glucose metabolism in schizophrenia: A high-resolution PET study using [
    Kim JH; Kim JH; Son YD; Joo YH; Lee SY; Kim HK; Woo MK
    Schizophr Res; 2017 Apr; 182():55-65. PubMed ID: 27760700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo evaluation of [
    Zhou X; Khanapur S; de Jong JR; Willemsen AT; Dierckx RA; Elsinga PH; de Vries EF
    J Cereb Blood Flow Metab; 2017 Feb; 37(2):577-589. PubMed ID: 26917190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Vivo Evaluation of
    Zhou X; Boellaard R; Ishiwata K; Sakata M; Dierckx RAJO; de Jong JR; Nishiyama S; Ohba H; Tsukada H; de Vries EFJ; Elsinga PH
    J Nucl Med; 2017 May; 58(5):762-767. PubMed ID: 28062599
    [No Abstract]   [Full Text] [Related]  

  • 35. Proof of mechanism study of a novel serotonin transporter blocker, DA-8031, using [11C]DASB positron emission tomography and in vivo microdialysis.
    Park HS; Jung IS; Lim NH; Sung JH; Lee S; Moon BS; Lee BC; Kang KK; Kim SE
    Urology; 2014 Jul; 84(1):245.e1-7. PubMed ID: 24824409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological and genetic characterization of two selective serotonin transporter ligands: 2-[2-(dimethylaminomethylphenylthio)]-5-fluoromethylphenylamine (AFM) and 3-amino-4-[2-(dimethylaminomethyl-phenylthio)]benzonitrile (DASB).
    Li Q; Ma L; Innis RB; Seneca N; Ichise M; Huang H; Laruelle M; Murphy DL
    J Pharmacol Exp Ther; 2004 Feb; 308(2):481-6. PubMed ID: 14610240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study.
    Matsumoto R; Ichise M; Ito H; Ando T; Takahashi H; Ikoma Y; Kosaka J; Arakawa R; Fujimura Y; Ota M; Takano A; Fukui K; Nakayama K; Suhara T
    Neuroimage; 2010 Jan; 49(1):121-6. PubMed ID: 19660554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Test-retest reliability of the novel 5-HT1B receptor PET radioligand [11C]P943.
    Saricicek A; Chen J; Planeta B; Ruf B; Subramanyam K; Maloney K; Matuskey D; Labaree D; Deserno L; Neumeister A; Krystal JH; Gallezot JD; Huang Y; Carson RE; Bhagwagar Z
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):468-77. PubMed ID: 25427881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology.
    Jonasson M; Wall A; Chiotis K; Saint-Aubert L; Wilking H; Sprycha M; Borg B; Thibblin A; Eriksson J; Sörensen J; Antoni G; Nordberg A; Lubberink M
    J Nucl Med; 2016 Apr; 57(4):574-81. PubMed ID: 26795290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of small-animal positron emission tomographic imaging of rats for preclinical development of drugs acting on the serotonin transporter.
    Saijo T; Maeda J; Okauchi T; Maeda J; Morio Y; Kuwahara Y; Suzuki M; Goto N; Suzuki K; Higuchi M; Suhara T
    Int J Neuropsychopharmacol; 2009 Sep; 12(8):1021-32. PubMed ID: 19236731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.